Laurion Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-19,872
Closed -$631K 1269
2018
Q2
$631K Buy
+19,872
New +$631K 0.01% 652